Insulet director Mazelsky acquires 141 stock units
The director's elected distribution may be made in a lump sum or substantially equal annual installments.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insulet Corp director Jonathan Jay Mazelsky acquired 141 deferred common stock units on September 30, 2026, in lieu of cash compensation under the Deferred Compensation Plan for Non-Employee Directors. The transaction lists a price of $130.47 per share, and the reported post-transaction position was 1,496 shares. The units convert one-for-one into common stock upon distribution; at his election, distribution may be a lump sum or substantially equal annual installments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 141 | $130.47 | $18K |
Footnotes (1)
- F1. These are deferred common stock units ("Deferred Units") received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution, with the value of any fractional shares paid in cash. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in substantially equal annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors.
Key Figures
Key Terms
Deferred Units financial
Deferred Compensation Plan for Non-Employee Directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.